Skip to main content
Drug Name EVUSHELD (tixagevimab with cilgavimab)
Drug Class
Vaccine
Risk minimization type
Direct Healthcare Professional Communication DHPC
Healthcare provider guide
patient guide
Specialty (Theraputic area)
Immunology
Risk
  • Updated dosage recommendations for EVUSHELD (tixagevimab co-packaged with cilgavimab) for pre-exposure prophylaxis against COVID-19
  • High-risk cardiac patients and the use of EVUSHELD (tixagevimab co packaged with cilgavimab)
  • risk of cardiovascular events
patient guide


Health care provider guide


Dear Healthcare provider letter DHPC